{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:14:06Z","timestamp":1792019646800,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474002"],"award-info":[{"award-number":["82474002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108031"],"award-info":[{"award-number":["82020108031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104290"],"award-info":[{"award-number":["82104290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023P-TS24"],"award-info":[{"award-number":["2023P-TS24"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010362"],"award-info":[{"award-number":["2023A1515010362"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.dmd.2025.100119","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:51:55Z","timestamp":1751889115000},"page":"100119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease"],"prefix":"10.1016","volume":"53","author":[{"given":"Xia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-lan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-xing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-pin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmd.2025.100119_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5694\/j.1326-5377.1962.tb20590.x","article-title":"The treatment of chronic ulcerative colitis with 6-mercaptopurine","volume":"49","author":"Bean","year":"1962","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.dmd.2025.100119_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/gutjnl-2019-320185","article-title":"Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource","volume":"70","author":"Stournaras","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dmd.2025.100119_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dmd.2025.100119_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.dmd.2025.100119_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","article-title":"Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience","volume":"34","author":"Connell","year":"1993","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/MIB.0000000000001148","article-title":"Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multicenter analysis","volume":"23","author":"Chao","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dmd.2025.100119_bib7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fphar.2018.01107","article-title":"Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring","volume":"9","author":"Lim","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5278","key":"10.1016\/j.dmd.2025.100119_bib8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.dmd.2025.100119_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","article-title":"Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer","volume":"8","author":"Karran","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.dmd.2025.100119_bib10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cpt.2730","article-title":"DNA-thioguanine nucleotides as a marker for thiopurine induced late leukopenia after dose optimizing by NUDT15 C415T in Chinese patients with IBD","volume":"112","author":"Zhu","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dmd.2025.100119_bib11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3748\/wjg.v30.i12.1751","article-title":"Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15\/TPMT normal metabolizers","volume":"30","author":"Yang","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100119_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1470-2045(17)30154-7","article-title":"DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial","volume":"18","author":"Nielsen","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.dmd.2025.100119_bib13","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/ecco-jcc\/jjad107","article-title":"Prevalence of NUDT15 genetic variants and incidence of thiopurine-induced leukopenia in inflammatory bowel disease: a systematic review and meta-analysis","volume":"17","author":"Yu","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.dmd.2025.100119_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ajh.25485","article-title":"Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: it takes two to tango","volume":"94","author":"Koutsilieri","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100119_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0000000000000282","article-title":"The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia","volume":"27","author":"Moriyama","year":"2017","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1016\/j.dmd.2025.100119_bib16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/cpt.2894","article-title":"Thiopurine methyltransferase intermediate metabolizer status and thiopurine-associated toxicity during maintenance therapy in childhood acute lymphoblastic leukemia","volume":"113","author":"Schwarz","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.cgh.2019.08.034","article-title":"Genotype-based treatment with thiopurine reduces incidence of myelosuppression in patients with inflammatory bowel diseases","volume":"18","author":"Chang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100119_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/apt.15403","article-title":"Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD","volume":"50","author":"van Gennep","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dmd.2025.100119_bib19","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/bcp.13943","article-title":"Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia","volume":"85","author":"Choi","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.13796","article-title":"NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease","volume":"44","author":"Zhu","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00535-018-1486-7","article-title":"NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study","volume":"53","author":"Kakuta","year":"2018","journal-title":"J Gastroenterol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ng.3060","article-title":"A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia","volume":"46","author":"Yang","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.dmd.2025.100119_bib23","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/bcp.14339","article-title":"Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease","volume":"86","author":"Choi","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100119_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40262-024-01393-0","article-title":"Innovating thiopurine therapeutic drug monitoring: a systematic review and meta-analysis on DNA-thioguanine nucleotides (DNA-TG) as an inclusive biomarker in thiopurine therapy","volume":"63","author":"Bayoumy","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100119_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115706","article-title":"Azathioprine dose tailoring based on pharmacogenetic information: insights of clinical implementation","volume":"168","author":"D\u00edaz-Villamar\u00edn","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.dmd.2025.100119_bib26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/apt.16600","article-title":"Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease","volume":"54","author":"Chao","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dmd.2025.100119_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5217\/ir.2017.15.3.328","article-title":"NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases","volume":"15","author":"Sato","year":"2017","journal-title":"Intest Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100119_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"7139","key":"10.1016\/j.dmd.2025.100119_bib29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.dmd.2025.100119_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cpt.1304","article-title":"Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update","volume":"105","author":"Relling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dmd.2025.100119_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/FTD.0b013e3182731925","article-title":"Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?","volume":"34","author":"Fangbin","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmd.2025.100119_bib32","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1038\/ncomms8871","article-title":"Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2","volume":"6","author":"Carter","year":"2015","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.dmd.2025.100119_bib33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","article-title":"Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia","volume":"33","author":"Yang","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100119_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jama.2019.0709","article-title":"Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease","volume":"321","author":"Walker","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.dmd.2025.100119_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jnci\/djae004","article-title":"Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations","volume":"116","author":"Maillard","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.dmd.2025.100119_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2036.2009.04057.x","article-title":"Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease","volume":"30","author":"Smith","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100119_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.taap.2018.06.015","article-title":"Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II)","volume":"353","author":"Stiburkova","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100119_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037724","article-title":"Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism","volume":"7","author":"Egeblad","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dmd.2025.100119_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2288-2-8","article-title":"Do multiple outcome measures require p-value adjustment?","volume":"2","author":"Feise","year":"2002","journal-title":"BMC Med Res Methodol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:43:59Z","timestamp":1762231439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0090955625091287"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100119","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100119"}}